Report Detail
Global Ziprasidone Market Insights, Forecast to 2025
- RnM3480153 |
- 31 May, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Chemical & Material
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.
Global Ziprasidone market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ziprasidone.
This report researches the worldwide Ziprasidone market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Ziprasidone breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Pfizer
Sandoz
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Apotex
Dr. Reddy's Laboratories
Wockhardt
Aurobindo
Macleods Pharmaceuticals
Zydus Pharmaceuticals
Ziprasidone Breakdown Data by Type
Oral capsule
Injection
Ziprasidone Breakdown Data by Application
Hospital
Drug store
Ziprasidone Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Ziprasidone Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Ziprasidone capacity, production, value, consumption, status and forecast;
To focus on the key Ziprasidone manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Ziprasidone :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
Global Ziprasidone Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
- 1.1 Ziprasidone Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Ziprasidone Market Size Growth Rate by Type
- 1.4.2 Oral capsule
- 1.4.3 Injection
- 1.5 Market by Application
- 1.5.1 Global Ziprasidone Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Drug store
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Ziprasidone Production
- 2.1.1 Global Ziprasidone Revenue 2014-2025
- 2.1.2 Global Ziprasidone Production 2014-2025
- 2.1.3 Global Ziprasidone Capacity 2014-2025
- 2.1.4 Global Ziprasidone Marketing Pricing and Trends
- 2.2 Ziprasidone Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Ziprasidone Manufacturers
- 2.4 Market Drivers, Trends and Issues
- 2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
- 3.1 Ziprasidone Production by Manufacturers
- 3.1.1 Ziprasidone Production by Manufacturers
- 3.1.2 Ziprasidone Production Market Share by Manufacturers
- 3.2 Ziprasidone Revenue by Manufacturers
- 3.2.1 Ziprasidone Revenue by Manufacturers (2014-2019)
- 3.2.2 Ziprasidone Revenue Share by Manufacturers (2014-2019)
- 3.3 Ziprasidone Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Ziprasidone Production by Regions
- 4.1 Global Ziprasidone Production by Regions
- 4.1.1 Global Ziprasidone Production Market Share by Regions
- 4.1.2 Global Ziprasidone Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States Ziprasidone Production
- 4.2.2 United States Ziprasidone Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Ziprasidone Import & Export
- 4.3 Europe
- 4.3.1 Europe Ziprasidone Production
- 4.3.2 Europe Ziprasidone Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Ziprasidone Import & Export
- 4.4 China
- 4.4.1 China Ziprasidone Production
- 4.4.2 China Ziprasidone Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Ziprasidone Import & Export
- 4.5 Japan
- 4.5.1 Japan Ziprasidone Production
- 4.5.2 Japan Ziprasidone Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Ziprasidone Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 Ziprasidone Consumption by Regions
- 5.1 Global Ziprasidone Consumption by Regions
- 5.1.1 Global Ziprasidone Consumption by Regions
- 5.1.2 Global Ziprasidone Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America Ziprasidone Consumption by Application
- 5.2.2 North America Ziprasidone Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe Ziprasidone Consumption by Application
- 5.3.2 Europe Ziprasidone Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Ziprasidone Consumption by Application
- 5.4.2 Asia Pacific Ziprasidone Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Ziprasidone Consumption by Application
- 5.5.2 Central & South America Ziprasidone Consumption by Countries
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Ziprasidone Consumption by Application
- 5.6.2 Middle East and Africa Ziprasidone Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa
6 Market Size by Type
- 6.1 Global Ziprasidone Breakdown Dada by Type
- 6.2 Global Ziprasidone Revenue by Type
- 6.3 Ziprasidone Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global Ziprasidone Breakdown Dada by Application
- 7.2.1 Global Ziprasidone Consumption by Application
- 7.2.2 Global Ziprasidone Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 Pfizer
- 8.1.1 Pfizer Company Details
- 8.1.2 Company Description
- 8.1.3 Capacity, Production and Value of Ziprasidone
- 8.1.4 Ziprasidone Product Description
- 8.1.5 SWOT Analysis
- 8.2 Sandoz
- 8.2.1 Sandoz Company Details
- 8.2.2 Company Description
- 8.2.3 Capacity, Production and Value of Ziprasidone
- 8.2.4 Ziprasidone Product Description
- 8.2.5 SWOT Analysis
- 8.3 Lupin Pharmaceuticals
- 8.3.1 Lupin Pharmaceuticals Company Details
- 8.3.2 Company Description
- 8.3.3 Capacity, Production and Value of Ziprasidone
- 8.3.4 Ziprasidone Product Description
- 8.3.5 SWOT Analysis
- 8.4 Mylan Pharmaceuticals
- 8.4.1 Mylan Pharmaceuticals Company Details
- 8.4.2 Company Description
- 8.4.3 Capacity, Production and Value of Ziprasidone
- 8.4.4 Ziprasidone Product Description
- 8.4.5 SWOT Analysis
- 8.5 Apotex
- 8.5.1 Apotex Company Details
- 8.5.2 Company Description
- 8.5.3 Capacity, Production and Value of Ziprasidone
- 8.5.4 Ziprasidone Product Description
- 8.5.5 SWOT Analysis
- 8.6 Dr. Reddy's Laboratories
- 8.6.1 Dr. Reddy's Laboratories Company Details
- 8.6.2 Company Description
- 8.6.3 Capacity, Production and Value of Ziprasidone
- 8.6.4 Ziprasidone Product Description
- 8.6.5 SWOT Analysis
- 8.7 Wockhardt
- 8.7.1 Wockhardt Company Details
- 8.7.2 Company Description
- 8.7.3 Capacity, Production and Value of Ziprasidone
- 8.7.4 Ziprasidone Product Description
- 8.7.5 SWOT Analysis
- 8.8 Aurobindo
- 8.8.1 Aurobindo Company Details
- 8.8.2 Company Description
- 8.8.3 Capacity, Production and Value of Ziprasidone
- 8.8.4 Ziprasidone Product Description
- 8.8.5 SWOT Analysis
- 8.9 Macleods Pharmaceuticals
- 8.9.1 Macleods Pharmaceuticals Company Details
- 8.9.2 Company Description
- 8.9.3 Capacity, Production and Value of Ziprasidone
- 8.9.4 Ziprasidone Product Description
- 8.9.5 SWOT Analysis
- 8.10 Zydus Pharmaceuticals
- 8.10.1 Zydus Pharmaceuticals Company Details
- 8.10.2 Company Description
- 8.10.3 Capacity, Production and Value of Ziprasidone
- 8.10.4 Ziprasidone Product Description
- 8.10.5 SWOT Analysis
9 Production Forecasts
- 9.1 Ziprasidone Production and Revenue Forecast
- 9.1.1 Global Ziprasidone Production Forecast 2019-2025
- 9.1.2 Global Ziprasidone Revenue Forecast 2019-2025
- 9.2 Ziprasidone Production and Revenue Forecast by Regions
- 9.2.1 Global Ziprasidone Revenue Forecast by Regions
- 9.2.2 Global Ziprasidone Production Forecast by Regions
- 9.3 Ziprasidone Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global Ziprasidone Production Forecast by Type
- 9.4.2 Global Ziprasidone Revenue Forecast by Type
10 Consumption Forecast
- 10.1 Consumption Forecast by Application
- 10.2 Ziprasidone Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America Ziprasidone Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Ziprasidone Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Ziprasidone Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Ziprasidone Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Ziprasidone Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
- 11.1 Analysis of Ziprasidone Upstream Market
- 11.1.1 Ziprasidone Key Raw Material
- 11.1.2 Typical Suppliers of Key Ziprasidone Raw Material
- 11.1.3 Ziprasidone Raw Material Market Concentration Rate
- 11.2 Ziprasidone Industry Chain Analysis
- 11.3 Marketing & Distribution
- 11.4 Ziprasidone Distributors
- 11.5 Ziprasidone Customers
12 Opportunities & Challenges, Threat and Affecting Factors
- 12.1 Market Opportunities
- 12.2 Market Challenges
- 12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Ziprasidone . Industry analysis & Market Report on Ziprasidone is a syndicated market report, published as Global Ziprasidone Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ziprasidone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
